featured
Personalized Dendritic Cell Vaccine After ASCT for Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Trial of a Personalized Dendritic Cell Vaccine after Autologous Stem Cell Transplant for Multiple Myeloma
Clin. Cancer Res 2023 Jul 18;[EPub Ahead of Print], DJ Chung, N Shah, J Wu, B Logan, L Bisharat, N Callander, G Cheloni, K Anderson, T Chodon, B Dhakal, S Devine, P Somaiya Dutt, Y Efebera, N Geller, H Ghiasuddin, P Hematti, L Holmberg, A Howard, B Johnson, D Karagkouni, HM Lazarus, E Malek, P McCarthy, D McKenna, A Mendizabal, A Nooka, N Munshi, L O'Donnell, AP Rapoport, J Reese, J Rosenblatt, R Soiffer, D Stroopinsky, L Uhl, IS Vlachos, EK Waller, JW Young, MC Pasquini, D AviganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.